Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective multicenter study of platinum-based versus non-platinum combination therapy for recurrent cervical cancer after prior platinum chemotherapy
jRCT1041250152Recruiting
- Start
- Mar 2026
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of carboplatin, cisplatin and paclitaxel in Cervical Cancer (CC) (2 arms). Primary endpoint: Progression-free survival. Started Mar 2026; status: recruiting.
02
Drugs
carboplatincisplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on jRCT1041250152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041250152.